| Product Name | MF | CAS | Details |
|---|
| OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD | C17H19N3O3S | Details |
| N,N'-Desethylene-N,N'-diforMyl Levofloxacin | C18H18FN3O6 | 151377-74-1 | Details |
| 1-Benzyl-4-[(5,6-diMethoxy-1H-inden-2-yl)Methyl]piperidine | C24H29NO2 | Details |
| Cabozantinib Impurity | C16H14N2O3 | 1355031-15-0 | Details |
| Norfloxacin Imp.(EP) | C34H52FN3O4 | 1911573-08-4 | Details |
| Cefixime Impurity | C17H16N2O4S | 33748-00-4 | Details |
| Amlodipine EP Impurity D | C20H23ClN2O5 | 113994-41-5 | Details |
| 2-[4-(2-Methylpropyl)phenyl] ethanol | C24H32O | 2143535-25-3 | Details |
| Lubiprostone IMpurity | Details |
| Group Doppler impurity | Details |
| Piperacillin Impurity | C17H20N4O6 | 2170771-47-6 | Details |
| 2-(4-ForMylphenyl)propionic Acid | C10H10O3 | Details |
| Argatroban iMpurity | C13H24N6O5 | 1448417-84-2 | Details |
| Vinpocetine Impurity | C19H23N3O | 102341-40-2 | Details |
| Lamivudine impurity | Details |
| Cetirizine IMpurity (4-Chlorobenzophenone) | C21H25ClN2O3 | 2724877-99-8 | Details |
| 4-PYRIDIN-4-YL-BUTYRIC ACID | C9H11NO2 | 102878-73-9 | Details |
| IMp. A (EP): 5-Methyl-2-[(2-nitrophenyl)-aMino]thiophene-3-carbonitrile | C17H20N4S | Details |
| acarbose iMpurity | Details |
| Fluconazole IMpurity [1, 3-Bis(1H-1, 2, 4-Triazole-1-yl)propan-2-one] | C10H7F2N3O | 1449785-88-9 | Details |
| Ezetimibe Impurity | C24H23F2NO2 | 1510820-22-0 | Details |
| Istradefylline iMpurity | Details |
| Clopidogrel | C16H16ClNO3S | 1319197-71-1 | Details |
| Benidipine Impurity | C12H11NO5 | 52604-00-9 | Details |
| Pabuximab impurity | Details |
| Afatinib impurity | Details |
| Clevidipine butyrate impurity | Details |
| Cefdinir impurity | Details |
| Clevidipine Butyrate Impurities | Details |
| NA | Details |
| Cinacalcet IMpurity | C22H26F3N | 1229224-93-4 | Details |
| SalMeterol iMpurity | C25H37NO4 | 144391-74-2 | Details |
| Montelukast iMpurity | Details |
| Riociguat IMpurtiy | 2920299-23-4 | Details |
| Diquafosol Impurity 1 | C18H24N4O17P2 | 26184-65-6 | Details |
| Terbinafine | C22H27N | 151222-50-3 | Details |
| 6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone | C12H13N3O3 | 1405180-57-5 | Details |
| Edaravone Impurity | Details |
| (S)-N-(1-AMino-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | C14H14N4O2 | 289472-80-6 | Details |
| Rivaroxaban iMpurity | C15H17N3O5 | 1616563-62-2 | Details |
| Methyl 4-Methylcinnamate | C11H12O2 | 7560-43-2 | Details |
| Eplerenone EP Impurity A | C23H28O5 | 209253-67-8 | Details |
| 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((4aR,7aS)-octahydropyrrolo [3,4-b]pyridin-6-yl)-8-Methoxy-4-oxoquinoline-3-carboxylic acid | C21H24FN3O4 | 1394029-14-1 | Details |
| Budesonide iMpurity | C24H32O6 | 192057-49-1 | Details |
| Dapoxetine iMpurity | C19H16O | 94305-25-6 | Details |
| Ivabradine IMpurity | C27H35ClN2O6 | 1616710-50-9 | Details |
| Pabuximab impurity | Details |
| Pabuxilibu impurities | Details |
| Bisoprolol | C18H31NO4 | 66722-44-9 | Details |
| IMp. A (EP): (RS)-9,10-Difluoro-3-Methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (FPA) | Details |
| Avibactam Impurity | C7H12N3NaO6S | 1797133-98-2 | Details |
| Entecavir Impurity | C12H15N5O3 | 1333204-94-6 | Details |
| cefdinir | Details |
| ethyl 4-hydroxy-2-oxopyrrolidine-1-acetate | C8H13NO4 | 62613-81-4 | Details |
| Azithromycin system suitability reference | Details |
| Irinotecan Hydroxyl Acid | C22H22N2O6 | 142677-15-4 | Details |
| AlviMopan iMpurity | Details |
| nifedipine iMpurity | C19H22N2O6 | Details |
| Rifaximin impurity B | C43H49N3O11 | 1351775-04-6 | Details |
| 1-(2,6-DICHLOROPHENYL)INDOLIN-2,3-DIONE | C14H7Cl2NO2 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||